Study Title: A Phase II Study of Naxitamab Added to Induction Therapy for Subjects with Newly Diagnosed High-Risk Neuroblastoma
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Jacqueline Kraveka, at kravekjm@musc.edu.Study Coordinator, Jared Hortman, at hortman@musc.edu.Trial opened at the following institutions: Medical University of South Carolina